Axit | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Axit
Canada

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Contact Supplier

xyz-pharma-m-2025-06-09

Contact Supplier

Axit

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 21 USDMF, 16 CEP/COS, 8 JDMF, 11 EU WC, 10 KDMF, 13 NDC API, 22 Listed Suppliers, $ API Reference Price

49 API Suppliers
21 USDMF
16 CEP/COS
8 JDMF
11 EU WC
10 KDMF
13 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

443 FDF Dossiers, 72 FDA Orange Book, 244 Europe, 36 Canada, 46 Australia, 22 South Africa, 23 Listed Dossiers

443 FDF Dossiers
72 FDA Orange Book
244 Europe
36 Canada
46 Australia
22 South Africa
23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 30MG, TABLET;ORAL - 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, TABLET, ORALLY DISINTEGRATING;ORAL - 45MG

TABLET;ORAL - 15MG
TABLET;ORAL - 30MG
TABLET;ORAL - 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG
TABLET, ORALLY DISINTEGRATING;ORAL - 30MG
TABLET, ORALLY DISINTEGRATING;ORAL - 45MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 4 Rochem International Inc, 20 SPI Pharma, 6 DKSH, 8 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 29 BASF, 1 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 39 Direct Compression, 37 Disintegrants & Superdisintegrants, 32 Taste Masking, 30 Granulation, 29 Thickeners and Stabilizers, 29 Controlled & Modified Release, 27 Solubilizers, 22 Chewable & Orodispersible Aids, 19 Lubricants & Glidants, 18 Film Formers & Plasticizers, 18 Co-Processed Excipients, 14 Topical, 14 Parenteral, 7 Emulsifying Agents, 7 Rheology Modifiers, 7 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

92 Fillers, Diluents & Binders
53 Coating Systems & Additives
39 Direct Compression
37 Disintegrants & Superdisintegrants
32 Taste Masking
30 Granulation
29 Thickeners and Stabilizers
29 Controlled & Modified Release
27 Solubilizers
22 Chewable & Orodispersible Aids
19 Lubricants & Glidants
18 Film Formers & Plasticizers
18 Co-Processed Excipients
14 Topical
14 Parenteral
7 Emulsifying Agents
7 Rheology Modifiers
7 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 13 News #PharmaBuzz

1 Data Compilation #PharmaFlow
13 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 226 Regulatory FDF Prices, 2 Annual Reports

2 US Medicaid Prescriptions
226 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

14 APIs, 2 FDF Dossiers

14 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 Others

2 EDQM
1 Others

$ API Ref.Price (USD/KG) : 375 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

36 All

01 3APOTEX INC

02 6AURO PHARMA INC

03 1DECHRA LTD

04 3MYLAN PHARMACEUTICALS ULC

05 3NORA PHARMA INC

06 4ORGANON CANADA

07 2PHARMASCIENCE INC

08 2PRO DOC LIMITEE

09 2Pharmascience Inc.

10 2SANDOZ CANADA INCORPORATED

11 2SANIS HEALTH INC

12 3SIVEM PHARMACEUTICALS ULC

13 3TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

36 All

01 34MIRTAZAPINE

02 2Mirtazapine

filter Dosage Form Reset all filters

36 All

01 1OINTMENT

02 29TABLET

03 6TABLET (ORALLY DISINTEGRATING)

filter Brand Name Reset all filters

36 All

01 3APO-MIRTAZAPINE

02 3AURO-MIRTAZAPINE

03 3AURO-MIRTAZAPINE OD

04 1MIRATAZ

05 5MIRTAZAPINE

06 3MYLAN-MIRTAZAPINE

07 3NRA-MIRTAZAPINE

08 4PMS-MIRTAZAPINE

09 2PRO-MIRTAZAPINE

10 1REMERON

11 3REMERON RD

12 2SANDOZ MIRTAZAPINE

13 3TEVA-MIRTAZAPINE

List of Suppliers

Product Main Page

01

APOTEX INC

IOPC

Not Confirmed

APOTEX INC

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : APO-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 30

Approval Date :

Application Number : 2286610

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

IOPC

Not Confirmed

APOTEX INC

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : APO-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 30MG

Packaging : 100

Approval Date :

Application Number : 2286629

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

IOPC

Not Confirmed

APOTEX INC

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : APO-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 45MG

Packaging : 30

Approval Date :

Application Number : 2286637

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pharmascience Inc.

IOPC

Not Confirmed

Pharmascience Inc.

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Mirtazapine

Brand Name : PMS-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 30MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

Pharmascience Inc.

IOPC

Not Confirmed

Pharmascience Inc.

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Mirtazapine

Brand Name : PMS-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

06

PHARMASCIENCE INC

IOPC

Not Confirmed

PHARMASCIENCE INC

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : PMS-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 100

Approval Date :

Application Number : 2273942

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

TEVA CANADA LIMITED

IOPC

Not Confirmed

TEVA CANADA LIMITED

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : TEVA-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number : 2259354

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MYLAN PHARMACEUTICALS ULC

IOPC

Not Confirmed

MYLAN PHARMACEUTICALS ULC

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : MYLAN-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 30/100

Approval Date :

Application Number : 2256096

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MYLAN PHARMACEUTICALS ULC

IOPC

Not Confirmed

MYLAN PHARMACEUTICALS ULC

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : MYLAN-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 30MG

Packaging : 30/100/500

Approval Date :

Application Number : 2256118

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MYLAN PHARMACEUTICALS ULC

IOPC

Not Confirmed

MYLAN PHARMACEUTICALS ULC

IOPC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MIRTAZAPINE

Brand Name : MYLAN-MIRTAZAPINE

Dosage Form : TABLET

Dosage Strength : 45MG

Packaging : 30/100

Approval Date :

Application Number : 2256126

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!